WHO launches studies on Ebola treatments and vaccines
The WHO has begun studies on treatment options against the Bundibugyo variant of the Ebola virus. The situation in the Democratic Republic of the Congo remains concerning.
The World Health Organization (WHO) announced today the initiation of studies on medications and vaccines against the Bundibugyo variant of the Ebola virus. This initiative comes in light of the current spread of the disease.
The WHO points out that the epidemic in the Democratic Republic of the Congo is continuing to progress rapidly, highlighting the urgency of the research projects.
We would like to count which pages are read — with our own statistics on our own server in Frankfurt am Main. No cookies are set for that and nothing is stored on your device. We ask nevertheless before we count. Without your consent the site remains fully usable — nothing is missing.
